EntryPoint Capital »

Kyverna Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $95k 10k 9.40

More positions owned by EntryPoint Capital

Charles Schwab Corporation (SCHW)
PNC Financial Services (PNC)
Ameriprise Financial (AMP)
Target Corporation (TGT)
Ares Management Corporation Cl A Com Stk (ARES)
UMH Properties (UMH)
Vici Pptys (VICI)
TJX Companies (TJX)
Service Corporation International (SCI)
Zoetis Cl A (ZTS)
Honeywell International (HON)
State Street Corporation (STT)
Marsh & McLennan Companies
News Corp Cl A (NWSA)
RBC Bearings Incorporated (RBC)

View all positions for EntryPoint Capital

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
RFG Advisory
Susquehanna International

View all funds holding Kyverna Therapeutics